A 32-year-old teacher in Fresno County, eight weeks postpartum, visited her midwife and completed the Edinburgh Postnatal Depression Scale, a ten-item questionnaire. Her score of 14 exceeded the threshold of 10 that typically prompts further assessment, leading to a same-day referral to a perinatal psychiatrist. Within a month, she began cognitive behavioral therapy and an antidepressant, and her symptoms improved. The screening, required by California law for licensed midwives, functioned as intended.

In contrast, a woman who delivered at a large hospital system in the same county received no such questionnaire at her six-week checkup. Her obstetrician asked, "How are you feeling?" She replied, "Fine." Six months later, she was diagnosed with major depression after struggling with sleep, appetite, and infant bonding. The disparity between these two outcomes reflects a systematic gap in postpartum mental health screening—one that California midwives are addressing, but that remains widespread across hospital-based care.

Postpartum Depression Screening Rates Vary by Provider Type

Postpartum depression (PPD) affects roughly 1 in 8 new mothers in the United States, according to data from the Centers for Disease Control and Prevention. The U.S. Preventive Services Task Force recommends screening all adults for depression, including pregnant and postpartum women, with adequate systems in place for follow-up. The American College of Obstetricians and Gynecologists and the American Academy of Pediatrics endorse routine screening using validated tools like the Edinburgh scale.

Yet the real-world screening rate is far lower than these guidelines suggest. A 2023 study in the journal Obstetrics & Gynecology found that only about half of obstetric providers reported routinely screening for PPD at postpartum visits. At well-child visits—where pediatricians see the infant but often miss the mother—the rate is even lower.

California midwives, however, are a different story. Under a state law passed in 2018, licensed midwives must offer depression screening to all postpartum patients. In one rural practice in Humboldt County, midwives screen more than 90% of their postpartum patients, according to a 2024 report from the California Maternal Quality Care Collaborative. Compare that to hospital-based OB units, where some estimates put screening rates near 40%.

The difference matters. When screening is done consistently, detection rates rise. The Edinburgh scale, when scored at a threshold of 13 or higher, has a sensitivity of about 85% for major depression. That means four out of five women with PPD are caught. Without screening, most are missed.

Midwives Achieve Higher Screening Rates Through Continuity of Care

Licensed midwives in California attend roughly 10% of all births in the state, a proportion that has grown steadily over the past decade. Their patients tend to be lower-risk and often have private insurance or Medi-Cal coverage. But the key advantage is not the patient mix—it is the model of care.

Midwives typically see the same woman throughout pregnancy, labor, and the postpartum period. This continuity means that a woman who has spent nine months with her midwife is more likely to disclose feelings of sadness, anxiety, or intrusive thoughts than she would to a rotating cast of hospital residents. "They know me," one patient in Sacramento told her midwife. "You're the one who was there when my baby was born."

This familiarity is associated with higher screening completion rates. In a 2022 survey of California midwives published in the Journal of Midwifery & Women's Health, 87% reported using the Edinburgh scale at the postpartum visit. The same survey of hospital-based obstetricians found only 44% did so.

The state mandate helps, but it is not the whole story. Midwives have integrated screening into their workflow as a standard part of care, not an optional add-on. In many practices, the Edinburgh form is handed to the patient at check-in, completed in the waiting room, and scored by the midwife during the visit. A positive result triggers a warm handoff to a perinatal mental health specialist, often via telehealth.

Still, midwives cannot close the gap alone. They see only a fraction of the state's 400,000 annual births. The vast majority of women deliver in hospitals, where the screening gap is widest.

Why Hospital Systems Drop the Ball

Hospital-based obstetric care is fragmented by design. After a woman delivers, she is discharged within 24 to 48 hours for a vaginal birth, or up to 96 hours for a cesarean. Her postpartum follow-up is often scheduled with the same obstetrician who delivered the baby—but that visit typically occurs at six weeks, leaving a six-week window of virtually no mental health monitoring.

Pediatricians see the infant at two weeks and again at one month, but they are trained to focus on the baby's growth, feeding, and vaccines. Asking about the mother's mood is not always part of the routine. A 2019 survey in Pediatrics found that only 30% of pediatricians routinely screened mothers for PPD, citing lack of time and uncertainty about referral resources.

Reimbursement is another barrier. Screening for depression is covered under the Affordable Care Act as a preventive service for adults, but the billing codes are often not used in the postpartum context. Some hospitals have electronic medical record alerts that prompt screening, but these alerts are frequently ignored amid time constraints. "We have 15 minutes per patient," one OB nurse told a state task force. "I can't add another questionnaire."

The result is a system that screens only a minority of postpartum women, despite clear evidence that early detection improves outcomes. For a condition that affects one in eight mothers, this is not a minor oversight—it is a systematic failure.

Evidence Supporting Universal Postpartum Depression Screening

The Edinburgh Postnatal Depression Scale is the most widely used tool for PPD screening. It consists of ten items, each scored 0 to 3, covering mood, anxiety, sleep, and self-harm thoughts. A score of 10 or higher suggests possible depression, while 13 or higher indicates a high probability of major depression. Validation studies across multiple countries have reported sensitivity of roughly 85% and specificity of 80% for the higher threshold.

When PPD is identified, treatment is effective. A meta-analysis of 28 randomized trials, published in the BMJ in 2021, found that cognitive behavioral therapy reduced PPD symptoms with an effect size of 0.65, comparable to that of selective serotonin reuptake inhibitors. Combination therapy—CBT plus an SSRI—showed response rates of 60–70% in several large trials.

Untreated PPD carries serious consequences. It is associated with preterm birth, low birth weight, and impaired mother-infant bonding. Children of depressed mothers are more likely to have behavioral problems and developmental delays. The economic costs are substantial: a 2020 RAND Corporation analysis estimated that untreated perinatal depression costs the U.S. health system roughly $14 billion per year in maternal and child health expenditures.

Cost-effectiveness models consistently show that universal screening pays for itself. A 2019 study in Health Affairs calculated that screening all postpartum women with the Edinburgh scale would save about $1,200 per screened dyad (mother and child) over five years, largely by averting costly emergency department visits and hospitalizations for severe depression.

Despite this evidence, screening remains uneven. California midwives have adopted it. Many hospitals have not. The gap is not about a lack of data—it is about a lack of system integration.

How Midwives Navigate Referral and Follow-Up

A positive screen is only the first step. Without a reliable pathway to treatment, screening can cause harm by identifying a problem that goes unaddressed. California midwives have developed referral networks that minimize this risk.

In many practices, a positive Edinburgh score triggers an immediate warm handoff to a perinatal psychiatrist or a licensed clinical social worker who specializes in maternal mental health. Telehealth has expanded access in the Central Valley and other rural areas where specialist shortages are acute. The California Perinatal Quality Collaborative has established a referral tracking system that monitors whether patients complete at least one follow-up visit within 30 days of a positive screen.

Some midwives also prescribe antidepressants under collaborative practice agreements with supervising physicians. California law allows midwives to prescribe a limited set of medications, including SSRIs, for depression. This authority is not widely used—only about 15% of licensed midwives have a collaborative agreement for psychiatric medications—but it is growing.

The bottleneck remains the shortage of perinatal mental health specialists. The state has roughly 200 board-certified reproductive psychiatrists for 400,000 births per year. Telehealth helps, but wait times for an initial appointment can still stretch to six weeks. Midwives often manage mild to moderate cases themselves, reserving specialist referrals for severe or treatment-resistant depression.

Despite these challenges, the midwifery model shows that screening can be done effectively when embedded in a system that prioritizes continuity and follow-up. The question is whether hospital-based care can adopt similar practices.

Policy Levers That Could Close the Gap

California's 2018 law requiring midwives to offer depression screening was a first step. A more ambitious policy would extend that requirement to all birthing hospitals. A proposed state bill, introduced in early 2025, would require hospitals to report their postpartum depression screening rates as a quality metric, with financial penalties for noncompliance. The bill has drawn support from the California Hospital Association but faces opposition from some physician groups who argue it adds administrative burden.

Medicare has already taken steps to close the gap. As of January 2024, the Centers for Medicare & Medicaid Services reimburses depression screening as a preventive service for postpartum women under the Medicare Part B benefit, and the Affordable Care Act requires most private plans to cover it without cost-sharing. But reimbursement alone does not ensure uptake. A 2023 analysis by the Kaiser Family Foundation found that only about 40% of commercial plans had implemented the screening benefit in a way that made it easy for providers to use.

Other policy ideas include embedding screening into the electronic health record as a mandatory field, similar to how vital signs are recorded. Some health systems have experimented with patient portal reminders that prompt women to complete the Edinburgh scale online before their visit. A pilot program at UC Davis Health found that portal-based self-reporting increased screening rates from 45% to 72% over six months.

Innovative technology companies are also entering the space. Oura Health, the Finnish company behind the Oura Ring, has explored whether sleep and activity data from its wearable device can serve as an early marker for postpartum depression. A small proof-of-concept study published in 2025 found that changes in sleep regularity and heart rate variability during the first four weeks postpartum correlated with Edinburgh scores at six weeks. The idea is not to replace screening but to flag women who might benefit from an earlier conversation. The approach is promising but far from validated for clinical use.

Yet enforcement and funding for follow-up remain weak. A screening mandate without a corresponding investment in mental health services is like a smoke alarm without a fire department. The state legislature has allocated $50 million over three years to expand perinatal mental health services, but advocates say that amount is a fraction of what is needed.

What Clinicians Can Do Tomorrow

While policymakers debate broader reforms, individual clinicians and practices can take steps to close the gap. The most straightforward is to adopt a single validated tool—the Edinburgh scale—and use it at every postpartum visit, not just the six-week check. Some practices have started screening at the two-week infant visit, catching depression earlier.

Scheduling a dedicated 15-minute mental health check at four to six weeks postpartum gives the mother a space to talk without the baby in the room. This simple structural change can increase disclosure rates. Partnering with local midwifery groups for cross-coverage can also help. In some regions, midwives have offered to train hospital nurses on how to administer and score the Edinburgh scale, sharing their workflows.

Using patient portal reminders for self-report before a visit reduces the time burden on clinicians. And documenting screening in the medical record ensures that it is captured for quality metrics and reimbursement. These are not revolutionary ideas. They are the same practices that California midwives have used for years.

But the gap will not close entirely until hospitals treat postpartum depression with the same seriousness as preeclampsia or hemorrhage—conditions for which screening and protocols are non-negotiable. The midwives have shown the way. The rest of the system has yet to follow.

For a parallel example of how evidence-based practices lag in real-world settings, see our earlier report on General Practice Prescribes Benzodiazepines for Anxiety While Therapy Waitlists Stretch Two Years. And for a look at how fragmented follow-up affects other conditions, read about UK Heart Failure Patients Log Own Symptoms While Clinics Ignore Daily Weight Data.

This article is for informational purposes only and does not constitute medical advice. Individual patients should consult their healthcare provider for guidance on screening and treatment options.